Endothelin-converting enzyme 1 promotes re-sensitization of neurokinin 1 receptor-dependent neurogenic inflammation

British Journal of Pharmacology

Volumn 156, Issue 5, 2009, Pages 730-739

  Cattaruzza, F ^a   Cottrell, G S ^a   Vaksman, N ^a   Bunnett, N W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endothelin converting enzyme 1; Neurogenic inflammation; Neurokinin 1 receptor; Substance P

Indexed keywords

CALCIUM; ENDOTHELIN CONVERTING ENZYME; ENDOTHELIN CONVERTING ENZYME INHIBITOR; N ACETYL 10,11 DIHYDRO 5H DIBENZO[A,D]CYCLOHEPTEN 5 YLGLYCYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; NEUROKININ 1 RECEPTOR; SM 19712; SUBSTANCE P; UNCLASSIFIED DRUG; ASPARTIC PROTEINASE; ENDOTHELIN-CONVERTING ENZYME 1; METALLOPROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DRUG EFFECT; ENDOCYTOSIS; ENDOTHELIUM CELL; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; MALE; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; BLADDER; CAPILLARY PERMEABILITY; CELL LINE; CYTOLOGY; EAR; ENDOSOME; METABOLISM; MICROVASCULATURE; PHYSIOLOGY; SKIN; SPRAGUE DAWLEY RAT; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ASPARTIC ENDOPEPTIDASES; CALCIUM; CALCIUM SIGNALING; CAPILLARY PERMEABILITY; CELL LINE; EAR; ENDOCYTOSIS; ENDOSOMES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MALE; METALLOENDOPEPTIDASES; MICROVESSELS; NEUROGENIC INFLAMMATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-1; SKIN; SUBSTANCE P; URINARY BLADDER;

EID: 66949127237     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2008.00039.x     Document Type: Article

References (38)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Azarani A, Boileau G, Crine P (1998). Recombinant human endothelin-converting enzyme ECE-1b is located in an intracellular compartment when expressed in polarized Madin-Darby canine kidney cells. Biochem J 333 : 439 448.
3. Bowden JJ, Garland AM, Baluk P, Lefevre P, Grady EF, Vigna SR et al. (1994). Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci USA 91 : 8964 8968.
4. Bowden JJ, Baluk P, Lefevre PM, Vigna SR, McDonald DM (1996). Substance P (NK1) receptor immunoreactivity on endothelial cells of the rat tracheal mucosa. Am J Physiol 270 : L404 I414.
5. Brain SD, Williams WJ, Tippins JR, Morris HR, MacIntyre I (1985). Calcitonin gene-related peptide is a potent vasodilator. Nature 313 : 54 56.
6. Brandli P, Loffler BM, Breu V, Osterwalder R, Maire JP, Clozel M (1996). Role of endothelin in mediating neurogenic plasma extravasation in rat dura mater. Pain 64 : 315 322.
7. Doherty AM, Cody WL, He JX, DePue PL, Cheng XM, Welch KM et al. (1993). In vitro and in vivo studies with a series of hexapeptide endothelin antagonists. J Cardiovasc Pharmacol 22 : S98 S102.
8. Drapeau G, D'Orleans-Juste P, Dion S, Rhaleb NE, Rouissi NE, Regoli D (1987). Selective agonists for substance P and neurokinin receptors. Neuropeptides 10 : 43 54. (Pubitemid 17130244)
9. Fahnoe DC, Knapp J, Johnson GD, Ahn K (2000). Inhibitor potencies and substrate preference for endothelin-converting enzyme-1 are dramatically affected by pH. J Cardiovasc Pharmacol 36 : S22 S25.
10. Grady EF, Baluk P, Bohm S, Gamp PD, Wong H, Payan DG et al. (1996). Characterization of antisera specific to NK1, NK2, and NK3 neurokinin receptors and their utilization to localize receptors in the rat gastrointestinal tract. J Neurosci 16 : 6975 6986.
11. Hall JM, Brain SD (1994). Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo. Br J Pharmacol 113 (2 522 526.
12. Hoang MV, Turner AJ (1997). Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin. Biochem J 327 : 23 26.
13. Hunter AR, Turner AJ (2006). Expression and localization of endothelin-converting enzyme-1 isoforms in human endothelial cells. Exp Biol Med 231 : 718 722.
14. Johnson GD, Stevenson T, Ahn K (1999). Hydrolysis of peptide hormones by endothelin-converting enzyme-1. A comparison with neprilysin. J Biol Chem 274 : 4053 4058.
15. Korth P, Bohle RM, Corvol P, Pinet F (1999). Cellular distribution of endothelin-converting enzyme-1 in human tissues. J Histochem Cytochem 47 : 447 462.
16. Lu B, Figini M, Emanueli C, Geppetti P, Grady EF, Gerard NP et al. (1997). The control of microvascular permeability and blood pressure by neutral endopeptidase. Nat Med 3 : 904 907.
17. McConalogue K, Corvera CU, Gamp PD, Grady EF, Bunnett NW (1998). Desensitization of the neurokinin-1 receptor (NK1-R) in neurons: effects of substance P on the distribution of NK1-R, Galphaq/11, G-protein receptor kinase-2/3, and beta-arrestin-1/2. Mol Biol Cell 9 : 2305 2324.
18. McDonald DM, Bowden JJ, Baluk P, Bunnett NW (1996). Neurogenic inflammation. A model for studying efferent actions of sensory nerves. Adv Exp Med Biol 410 : 453 462.
19. Macours N, Hens K (2004). Zinc-metalloproteases in insects: ACE and ECE. Insect Biochem Mol Biol 34 : 501 510.
20. Matsas R, Kenny AJ, Turner AJ (1984). The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11. Biochem J 223 : 433 440.
21. Meidan R, Klipper E, Gilboa T, Muller L, Levy N (2005). Endothelin-converting enzyme-1, abundance of isoforms a-d and identification of a novel alternatively spliced variant lacking a transmembrane domain. J Biol Chem 280 : 40867 40874.
22. Muller L, Barret A, Etienne E, Meidan R, Valdenaire O, Corvol P et al. (2003). Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease. J Biol Chem 278 : 545 555.
23. Padilla BE, Cottrell GS, Roosterman D, Pikios S, Muller L, Steinhoff M et al. (2007). Endothelin-converting enzyme-1 regulates endosomal sorting of calcitonin receptor-like receptor and beta-arrestins. J Cell Biol 179 : 981 997.
24. Quinlan KL, Song IS, Bunnett NW, Letran E, Steinhoff M, Harten B et al. (1998). Neuropeptide regulation of human dermal microvascular endothelial cell ICAM-1 expression and function. Am J Phys 275 : C1580 C1590.
25. Roosterman D, Cottrell GS, Schmidlin F, Steinhoff M, Bunnett NW (2004). Recycling and re-sensitization of the neurokinin 1 receptor. Influence of agonist concentration and Rab GTPases. J Biol Chem 279 : 30670 30679.
26. Roosterman D, Cottrell GS, Padilla BE, Muller L, Eckman CB, Bunnett NW et al. (2007). Endothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling. Proc Natl Acad Sci USA 104 : 11838 11843.
27. Roosterman D, Kempkes C, Cottrell GS, Padilla BE, Bunnett NW, Turck CW et al. (2008). Endothelin-converting enzyme-1 degrades internalized somatostatin-14. Endocrinology 149 : 2200 2207.
28. Russell FD, Davenport AP (1999). Secretory pathways in endothelin synthesis. Br J Pharmacol 126 : 391 398.
29. Russell FD, Skepper JN, Davenport AP (1998). Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res 83 : 314 321.
30. Schweizer A, Valdenaire O, Nelbock P, Deuschle U, Milne Edwards D, Stumpf JB et al. (1997). Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem J 328 : 871 877.
31. Smith CH, Barker JN, Morris RW, MacDonald DM, Lee TH (1993). Neuropeptides induce rapid expression of endothelial cell adhesion molecules and elicit granulocytic infiltration in human skin. J Immunol 151 : 3274 3282.
32. Sturiale S, Barbara G, Qiu B, Figini M, Geppetti P, Gerard N et al. (1999). Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci USA 96 : 11653 11658.
33. Turner AJ, Isaac RE, Coates D (2001). The neprilysin (NEP) family of zinc metalloendopeptidases: genomics and function. Bioessays 23 (3 261 269.
34. Turner AJ, Murphy LJ (1996). Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 51 : 91 102.
35. Umekawa K, Hasegawa H, Tsutsumi Y, Sato K, Matsumura Y, Ohashi N (2000). Pharmacological characterization of a novel sulfonylureid-pyrazole derivative, SM-19712, a potent nonpeptidic inhibitor of endothelin converting enzyme. Jpn J Pharmacol 84 : 7 15. (Pubitemid 30777253)
36. Valdenaire O, Rohrbacher E, Mattei MG (1995). Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J Biol Chem 270 : 29794 29798.
37. Valdenaire O, Lepailleur-Enouf D, Egidy G, Thouard A, Barret A, Vranckx R et al. (1999). A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization. Eur J Biochem 264 : 341 349.
38. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D et al. (1994). ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78 : 473 485.